Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
0.675
+0.047 (7.50%)
At close: Nov 22, 2024, 4:00 PM
0.670
-0.005 (-0.70%)
After-hours: Nov 22, 2024, 5:44 PM EST
Veru Inc. Market Cap
Veru Inc. has a market cap or net worth of $98.81 million as of November 22, 2024. Its market cap has increased by 11.65% in one year.
Market Cap
98.81M
Enterprise Value
83.34M
1-Year Change
11.65%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since February 11, 1999, Veru Inc.'s market cap has increased from $17.00M to $98.81M, an increase of 481.23%. That is a compound annual growth rate of 7.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 91.80M | 36.20% |
Dec 29, 2023 | 67.40M | -84.17% |
Dec 30, 2022 | 425.70M | -9.69% |
Dec 31, 2021 | 471.40M | -22.24% |
Dec 31, 2020 | 606.20M | 178.20% |
Dec 31, 2019 | 217.90M | 148.46% |
Dec 31, 2018 | 87.70M | 44.48% |
Dec 29, 2017 | 60.70M | 112.98% |
Dec 30, 2016 | 28.50M | -32.30% |
Dec 31, 2015 | 42.10M | -62.74% |
Dec 31, 2014 | 113.00M | -53.73% |
Dec 31, 2013 | 244.20M | 18.60% |
Dec 31, 2012 | 205.90M | 63.80% |
Dec 30, 2011 | 125.70M | -19.63% |
Dec 31, 2010 | 156.40M | 24.42% |
Dec 31, 2009 | 125.70M | 30.39% |
Dec 31, 2008 | 96.40M | 38.31% |
Dec 31, 2007 | 69.70M | 85.87% |
Dec 29, 2006 | 37.50M | -7.64% |
Dec 30, 2005 | 40.60M | -11.74% |
Dec 31, 2004 | 46.00M | -14.34% |
Dec 31, 2003 | 53.70M | 88.42% |
Dec 31, 2002 | 28.50M | 139.50% |
Dec 31, 2001 | 11.90M | 80.30% |
Dec 29, 2000 | 6.60M | -54.79% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Anixa Biosciences | 102.97M |
Century Therapeutics | 102.89M |
Fractyl Health | 100.53M |
Immunic | 99.09M |
Harvard Bioscience | 99.00M |
PetMed Express | 98.63M |
Nuvectis Pharma | 98.54M |
Leap Therapeutics | 97.57M |